Further evidence for a role of arachidonic acid in glucocorticoid teratogenic action in the palate.
Arachidonic acid produces a significant reversal of the production of cleft palate by cortisone in the offspring of sensitive strains of mice in vivo. Arachidonic acid in nanogram per milliliter concentrations also produces a significant reversal of the cortisol inhibition of the programmed cell death of the medial edge epithelium of palatal shelves in vitro. This corrective action of arachidonic acid in vitro is significantly blocked by indomethacin at a nanogram per milliliter concentration which selectively inhibits the conversion of arachidonic acid to prostaglandins and/or thromboxanes at the level of cyclooxygenase. These results support the hypothesis that the inhibition of arachidonic acid release and subsequent prostaglandin and/or thromboxane production by glucocorticoids is involved in the teratogenic action of glucocorticoids and demonstrate that one site of this action is the inhibition of epithelial loss.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000502:physiology*; D002478:Cells, Cultured; D002972:Cleft Palate / Q000139:chemically induced*; D003348:Cortisone / Q000037:antagonists & inhibitors*; D005260:Female; D006854:Hydrocortisone / Q000037:antagonists & inhibitors; D007213:Indomethacin / Q000494:pharmacology; D051379:Mice; D011247:Pregnancy
D001095:Arachidonic Acids; D016718:Arachidonic Acid; D003348:Cortisone; D006854:Hydrocortisone; D007213:Indomethacin